APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch

This Italian registry study is collecting real-world data on lung cancer patients receiving innovative treatments — including immunotherapy, targeted therapies, and next-generation drugs. The goal is to understand how these treatments perform outside of clinical trial settings. **You may be eligible if...** - You are 18 years or older - You have been diagnosed with non-small cell or small cell lung cancer at any stage - You are receiving or have received innovative therapies (such as immunotherapy, targeted therapy, or next-generation treatments) **You may NOT be eligible if...** - You have only received local treatments (surgery or radiation only) without systemic therapy - You are receiving another unapproved cancer treatment at the same time - You have not received any innovative systemic therapy Talk to your doctor to see if this trial is right for you.